The Patent Finder

Terms ending in 2033

BioAtla Inc.

Every in-force patent on BioAtla Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,696,750Multi-Specific Monoclonal Antibodies
In force
 · High confidence
BioAtla, Inc.In forceHigh confidence
US 12,595,592Comprehensive Monoclonal Antibody Generation
In force
 · Low confidence
BioAtla, Inc.In forceLow confidence
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited